Note: This document contains side effect information about ethinyl estradiol / norgestimate. Some dosage forms listed on this page may not apply to the brand name Tri-Estarylla.
Applies to ethinyl estradiol / norgestimate: oral tablet.
Warning
Oral route (Tablet)
Cigarette smoking increases the risk of serious cardiovascular side effects from combination oral contraceptive use. This risk increases with age and the number of cigarettes smoked and is quite marked in women over 35 years of age. Use of combination oral contraceptives is contraindicated in women over the age of 35 who smoke
Serious side effects of Tri-Estarylla
Along with its needed effects, ethinyl estradiol/norgestimate may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking ethinyl estradiol/norgestimate:
Incidence not known
- Absent, missed, or irregular menstrual periods
- anxiety
- change in vision
- changes in skin color
- chest pain or discomfort
- chills
- clay-colored stools
- constipation
- cough
- dark urine
- diarrhea
- dizziness or lightheadedness
- fainting
- fever
- headache
- hives or welts
- itching skin
- large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs
- loss of appetite
- medium to heavy, irregular vaginal bleeding between regular monthly periods, which may require the use of a pad or a tampon
- nausea
- pain or discomfort in the arms, jaw, back, or neck
- pain, tenderness, or swelling of the foot or leg
- pains in the chest, groin, or legs, especially in the calves of the legs
- pounding in the ears
- rash
- redness of the skin
- severe headaches of sudden onset
- slow or fast heartbeat
- stomach pain
- sudden loss of coordination or slurred speech
- sudden trouble breathing
- sweating
- unusual tiredness or weakness
- vomiting
- vomiting of blood
Other side effects of Tri-Estarylla
Some side effects of ethinyl estradiol/norgestimate may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Incidence not known
- Bloating
- blotchy spots on the exposed skin
- breast enlargement or tenderness
- discouragement
- feeling sad or empty
- irritability
- itching of the vagina or outside the genitals
- loss of interest or pleasure
- pain during sexual intercourse
- stomach cramps
- thick, white curd-like vaginal discharge without odor or with mild odor
- tiredness
- trouble concentrating
- trouble sleeping
- trouble wearing contact lenses
For Healthcare Professionals
Applies to ethinyl estradiol / norgestimate: oral tablet.
General
The most frequently reported side effects were headache/migraine, nausea/vomiting, gastrointestinal disorder, diarrhea, abdominal/gastrointestinal pain, vaginal infection, genital discharge, breast issues (including breast pain, discharge, and enlargement), dysmenorrhea, metrorrhagia, abnormal withdrawal bleeding, mood disorders (including depression and mood altered), flatulence, nervousness, rash, and changes in weight (including weight increased or decreased).[Ref]
Genitourinary
Very common (10% or more): Breast issues (10.3%), dysmenorrhea, metrorrhagia, abnormal withdrawal bleeding
Common (1% to 10%): Vaginal infection, genital discharge, breast tenderness, breast pain, breast enlargement, breast swelling, breast discharge, breast discomfort, nipple pain, menstrual discomfort, menstrual disorder, vulvovaginal infection, urinary tract infection, amenorrhea, premenstrual syndrome
Uncommon (0.1% to 1%): Ovarian cyst, vulvovaginal dryness
Rare (less than 0.1%): Vaginal discharge
Frequency not reported: Suppressed lactation[Ref]
Some women experience oligomenorrhea and amenorrhea following termination or oral contraceptive use.[Ref]
Gastrointestinal
Very common (10% or more): Nausea/vomiting (16.3%), gastrointestinal disorder, diarrhea
Common (1% to 10%): Abdominal/gastrointestinal pain, flatulence, abdominal distention, constipation
Rare (less than 0.1%): Pancreatitis[Ref]
Nervous system
Very common (10% or more): Headache/migraine (up to 33.6%)
Common (1% to 10%): Dizziness
Uncommon (0.1% to 1%): Syncope, paresthesia
Frequency not reported: Convulsion, cerebrovascular accident[Ref]
Cardiovascular
Uncommon (0.1% to 1%): Palpitation, thrombosis, hypertension, hot flush
Rare (less than 0.1%): Tachycardia, arterial thromboembolism
Frequency not reported: Myocardial infarction, venous thromboembolic event, deep vein thrombosis[Ref]
Respiratory
Uncommon (0.1% to 1%): Dyspnea
Frequency not reported: Pulmonary embolism[Ref]
Dermatologic
Common (1% to 10%): Rash, acne
Uncommon (0.1% to 1%): Alopecia, hirsutism, urticaria, pruritus, erythema, skin discoloration
Rare (less than 0.1%): Hyperhidrosis, photosensitivity reaction
Frequency not reported: Angioedema, erythema nodosum, night sweats[Ref]
Metabolic
Common (1% to 10%): Weight fluctuation, fluid retention
Rare (less than 0.1%): Appetite disorder
Frequency not reported: Dyslipidemia[Ref]
Musculoskeletal
Common (1% to 10%): Muscle spasms, pain in extremity, back pain
Uncommon (0.1% to 1%): Myalgia[Ref]
Oncologic
Uncommon (0.1% to 1%): Cervical dysplasia
Rare (less than 0.1%): Breast cyst
Frequency not reported: Breast cancer, carcinoma of the cervix in situ, hepatic adenoma, breast cancer, benign breast neoplasm, focal nodular hyperplasia, fibroadenoma of breast[Ref]
Hepatic
Rare (less than 0.1%): Hepatitis[Ref]
Psychiatric
Common (1% to 10%): Depression, mood altered, mood disorder, nervousness, insomnia
Uncommon (0.1% to 1%): Anxiety, libido disorder
Frequency not reported: Irritability, mood swing[Ref]
Immunologic
Common (1% to 10%): Hypersensitivity[Ref]
Other
Common (1% to 10%): Weight increased, weight decreased, fatigue, chest pain, asthenic conditions, edema[Ref]
Ocular
Uncommon (0.1% to 1%): Vision impaired, dry eye
Frequency not reported: Contact lens intolerance, retinal vascular thrombosis[Ref]